NVDA
NVIDIA
-- 118.690 TSLA
Tesla
-- 300.040 MSTR
Strategy
-- 265.670 PLTR
Palantir
-- 89.073 INTC
Intel
-- 24.405 
NEWS
Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival
Relay Therapeutics (RLAY) announced updated interim data for RLY-2608, showing an 11.4-month median progression-free survival in second-line patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer at the recommended Phase 2 dose. The study demonstrated a 39% confirmed objective response rate across all patients and 67% in patients with kinase mutations.
The drug showed a favorable tolerability profile, with 94% median dose intensityand mostly low-grade treatment-related adverse events. Among 64 patients at the recommended dose, only 31% experienced Grade 3 adverse events, with no Grade 4-5 events reported.
The company plans to initiate a pivotal Phase 2 study in 2025 and reported approximately $840 million in cash and investments as of Q3 2024.
Relay Therapeutics (RLAY) announced updated interim data for RLY-2608, showing an 11.4-month median progression-free survival in second-line patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer at the recommended Phase 2 dose. The study demonstrated a 39% confirmed objective response rate across all patients and 67% in patients with kinase mutations.
The drug showed a favorable tolerability profile, with 94% median dose intensityand mostly low-grade treatment-related adverse events. Among 64 patients at the recommended dose, only 31% experienced Grade 3 adverse events, with no Grade 4-5 events reported.
The company plans to initiate a pivotal Phase 2 study in 2025 and reported approximately $840 million in cash and investments as of Q3 2024.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Trytosaveabit : How’s that sleep going? Hehehe
Jaguar8 OP Trytosaveabit : Only had 30minutes![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Trytosaveabit Jaguar8 OP : Grrr!
Jaguar8 OP Trytosaveabit : I think I’ll sleep again![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Trytosaveabit Jaguar8 OP : Ok!